Document Detail


Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage.
MedLine Citation:
PMID:  21479679     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Elevated levels of B-type natriuretic peptide (BNP) have been associated with cardiac dysfunction and adverse neurological outcomes after subarachnoid hemorrhage (SAH). We sought to determine whether elevated levels of BNP are independently associated with radiographic cerebral infarction after SAH.
METHODS: Plasma BNP levels were measured after admission, a mean of 5.5 ± 3.0 days after SAH onset. Cerebral infarction was determined by retrospective review of computerized tomography (CT) scans. Cerebral vasospasm was confirmed by the presence of vascular narrowing on cerebral angiogram. The association between BNP and cerebral infarction was quantified using multivariable logistic regression and reverse stepwise elimination of clinical covariates. A stratified analysis was performed to quantify the association between BNP levels and infarction in patients with and without angiographic vasospasm.
RESULTS: BNP levels were measured from 119 subjects. The median BNP level was 105 pg/ml (interquartile range 37-275 pg/ml). In our multivariable model, the top quartile of BNP levels (≥ 276 pg/ml) were associated with an increased odds of cerebral infarction (OR 4.2, P = 0.009). The stratified analysis showed that the association between BNP and infarction was strongest in patients without angiographic vasospasm (OR 7.8, P = 0.006).
CONCLUSIONS: Elevated levels of BNP are strongly and independently associated with cerebral infarction, and the association is most pronounced in patients without angiographic vasospasm. These results provide further evidence that other mechanisms can contribute to infarction, and BNP may be a useful biomarker in detecting patients at risk for adverse outcomes without large vessel vasospasm.
Authors:
Pam R Taub; Jeremy D Fields; Alan H B Wu; Jacob C Miss; Michael T Lawton; Wade S Smith; William L Young; Jonathan G Zaroff; Nerissa U Ko
Related Documents :
21345779 - Levitronix centrimag pump as perioperative left ventricular support in a patient with c...
9322149 - Troponin i as a specific marker for heart damage after heart transplantation in a patie...
9226229 - Creatine kinase subform analysis in hemodialysis patients without acute coronary syndro...
19394809 - Superparamagnetic microsphere-assisted fluoroimmunoassay for rapid assessment of acute ...
21241969 - Combination stem cell therapy for the treatment of medically refractory coronary ischem...
19889409 - Cardiac injury and troponin testing after orthopaedic surgery.
20543669 - Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary interve...
15886379 - Association between phonocardiographic third and fourth heart sounds and objective meas...
8890799 - Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neurocritical care     Volume:  15     ISSN:  1556-0961     ISO Abbreviation:  Neurocrit Care     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-11     Completed Date:  2012-01-19     Revised Date:  2014-09-05    
Medline Journal Info:
Nlm Unique ID:  101156086     Medline TA:  Neurocrit Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  13-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Biological Markers / blood
Cerebral Infarction / blood*,  etiology,  radiography*
Cohort Studies
Female
Humans
Male
Middle Aged
Natriuretic Peptide, Brain / blood*
Subarachnoid Hemorrhage / blood*,  complications,  radiography
Tomography, X-Ray Computed
Vasospasm, Intracranial / blood*,  etiology,  radiography
Grant Support
ID/Acronym/Agency:
1R21 NS050551-01/NS/NINDS NIH HHS; K02 NS060892/NS/NINDS NIH HHS; K02 NS060892-04/NS/NINDS NIH HHS; K02 NS60892/NS/NINDS NIH HHS; K23 HL04054-01A1/HL/NHLBI NIH HHS; K23 NS044014/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 114471-18-0/Natriuretic Peptide, Brain
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative sequence analysis of representative foot-and-mouth disease virus genomes from Southeast ...
Next Document:  Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL/RANK signalling r...